Skip to main content
. 2019 Dec 12;49:202–209. doi: 10.1016/j.breast.2019.12.002

Fig. 4.

Fig. 4

PRAME immunohistochemical expression. a) PRAME positive staining in a lobular carcinoma (x 40, anti-PRAME). b) PRAME positive staining in a carcinoma of moderately endocrine-responsive group (x 40, anti-PRAME). c,d) PRAME positive staining in two cases of breast carcinoma with HER2 overexpression (x 40, anti-PRAME).